论文信息 - Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 - 字舞流文

Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1

B. Klein | D. Hose | H. Goldschmidt | A. Krämer | A. Ho | Ludmila Weiz | K. Podar | Verena Wagner | A. Seckinger | M. Raab | T. Meissner | T. Rème | I. Breitkreutz